NCT06948955 2026-03-09Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal TumorsCogent Biosciences, Inc.Available
NCT06872489 2025-07-23Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid TumorsSecond Life TherapeuticsAvailable